Dencare (Chongqing) Oral Care Co., Ltd. Class A

Dencare (Chongqing) Oral Care Co., Ltd. Class A

SSZSE:001328
32.51
CNY
+2.96
(+10.02%)
1.09EPS
23.67P/E
4.46BMarket Cap
Apr 28Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.97
8.54
8.84
10.15
8.57
9.1
9.95
10.8
Basic EPS, GAAP
0.6
0.79
0.92
1.04
0.88
0.94
1.05
1.09
Free Cash Flow per Basic Share
0.49
1.08
0.38
0.22
0.66
0.78
0.96
- -
Dividend per Share
0.3
0.4
1.18
0.78
0.64
0.65
0.75
- -
Book Value per Share
3.7
4.14
3.94
4.2
8.16
8.45
8.74
8.56
Tangible Book Value per Share
3.56
4.01
3.81
4.08
8.07
8.33
8.62
8.43
Basic Weighted Avg Shares
105
121
129
129
161
171
172
172
Sales/Revenue/Turnover
944
1,030
1,143
1,313
1,376
1,560
1,716
1,860
Operating Margin (%)
7.04
9.58
10.78
10.4
8.78
10.23
10.47
10.22
Depreciation Expense
10
11
11
10
13
21
22
- -
Net Income, GAAP
63
95
119
135
141
161
181
189
Effective Tax Rate (%)
7.24
10.45
11.78
7.65
12.14
13.75
13.13
13.36
Profit Margin (%)
6.69
9.25
10.4
10.25
10.27
10.33
10.55
10.14
Working Capital
318
284
243
275
1,188
1,049
1,069
1,122
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
430
508
509
542
1,405
1,454
1,505
1,473
Return on Invested Capital (%)
- -
20.93
22.9
24.82
13.24
11.12
11.86
12.27
Return on Capital (%)
- -
21.9
24.77
25.94
14.64
11.34
12.28
12.74
Return on Common Equity (%)
- -
20.31
23.39
25.62
14.51
11.27
12.24
12.69

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
172
172
172
Market Capitalization
6,797
5,458
4,461

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,522
1,661
1,600
Cash, Cash Equivalents & STI
1,130
1,118
1,045
Accounts Receivable, Net
28
36
51
Inventories
178
187
199
Total Current Liabilities
452
477
478
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
34.59%
3.48%
Free Cash Flow
- -
44.99%
23.21%
Net Income, GAAP
- -
13.89%
12.35%
Sales/Revenue/Turnover
- -
10.81%
9.98%
Total Cash Common Dividend
- -
40.97%
15.38%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
361
343
350
507
1,560
2025
430
411
- -
488
1,716
2026
495
466
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.22
0.2
0.26
0.25
0.94
2025
0.25
0.24
- -
0.26
1.05
2026
0.3
0.29
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.49
- -
0.65
2025
- -
- -
- -
- -
0.75
2026
- -
- -
- -
- -
- -

Company Description

CEO
Feng Shuo Zhao
Full Time Employees
1,044
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Chongqing China
IPO Date
Apr 10, 2023
Business
Dencare (Chongqing) Oral Care Co., Ltd. is a China-based consumer goods company primarily engaged in the research, development, manufacturing, and marketing of oral health and personal hygiene products. Founded in 2001 and headquartered in Chongqing, China, the company operates across adult oral care, pediatric oral care, electric oral care, and professional medical oral care segments. Its product portfolio includes anti-sensitivity, whitening, and gum-health toothpastes under its flagship Lengsuanling brand; pediatric toothpastes and children toothbrushes under the Beilejia brand; manual, antibacterial, and sonic electric toothbrushes; therapeutic and cosmetic mouthwashes, oral rinses, and freshening sprays; interdental picks, dental floss, and cordless water flossers; denture cleaning tablets and fixative creams; and clinical dental consumables and specialized medical oral treatment products under the Dencare and Yikeling brand names. Dencare distributes its offerings nationwide across mainland China through a comprehensive omnichannel network spanning traditional grocery channels, hypermarkets, convenience store chains, community pharmacies, dental clinics, and major e-commerce and social commerce platforms, with select distribution in overseas markets. In recent corporate developments, the company listed its Class A shares on the Main Board of the Shenzhen Stock Exchange under the ticker 001328, allocating capital toward the development of smart production lines, digital supply chain infrastructure, and an upgraded oral healthcare research center. The company has also executed a strategic expansion beyond conventional chemical oral hygiene by rolling out intelligent sonic toothbrushes, clinical-grade desensitizing gels, and targeted orthodontic oral care lines, alongside entering strategic collaborative partnerships with national dental research institutes to accelerate product innovation.